The focus of the course will be clinical aspects of some of the more common types of cancer. A panel of top Israeli and foreign key opinion leaders will each lecture about their own field of expertise, namely a specific type of cancer. We will allocate 2 hours to each lecturer. The first 45-50 minutes will provide the facts and current mainstay, such as historical notes, disease course, epidemiology, etiology, pathology, cellular and immunohistochemical basis, subtypes and classifications, mutations and genetics, molecular mechanisms and major drugs and treatment protocols currently available. The second part (50 minutes; after a break), will address open questions of current research, including experimental drugs, response and resistance to drugs, roles (if any) of stem cells, availability of animal models, landmark publications, and more. The list of clinical indications includes lung and breast cancer, blood cancer, such as leukemia and lymphoma, liver, colon and rectum, and prostate cancer.